Catyalyst Pharmaceutical Partners (CPRX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.45 +0.03%
EPS Growth %: -30.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
CRMT, More
EPS Growth %: -30.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- General Mills (GIS) PT Lowered to $42 at Freedom Broker
- Six Flags names Mark Pauls as chief operating officer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
